文献速递肿瘤 PET/CT神经核医学

18F-MFBG与68Ga-DOTA-TATE PET/CT在疑似复发/难治性神经母细胞瘤中的头对头前瞻性比较

Head-to-Head Comparison of [ 18 F]MFBG and [ 68 Ga]Ga-DOTA-TATE PET/CT in Suspected Recurrent/Refractory Neuroblastoma: Prospective Single-center Analysis.
PubMed 文献 · Clin Nucl Med · 2026-01-20

该前瞻性单中心研究纳入28例疑似复发/难治性神经母细胞瘤患儿,在1周内分别行18F-MFBG和68Ga-DOTA-TATE PET/CT。两种显像剂在患者水平一致性高,区域水平灵敏度相近,但18F-MFBG特异性更高,主要源于骨/骨髓转移灶SUVmax更高;两者摄取模式互补,联合可提高诊断信心并优化疗效反应分类。

要点

  • 18F-MFBG与68Ga-DOTA-TATE PET/CT在疑似复发/难治性神经母细胞瘤患儿中患者水平一致性高。
  • 区域水平18F-MFBG灵敏度93.0%、特异性96.4%、AUC 0.947;68Ga-DOTA-TATE分别为95.4%、86.6%、0.910。
  • 骨/骨髓转移灶18F-MFBG中位SUVmax 5.21,高于68Ga-DOTA-TATE的2.90(P<0.0001)。

核心结论

  • 18F-MFBG与68Ga-DOTA-TATE PET/CT均可有效评估复发或转移性神经母细胞瘤,因正常器官和良性病变摄取较低。
  • 两种显像因肿瘤空间异质性在检测和疗效反应评估中具有互补价值。

主要发现

  • 患者水平:两种扫描均阳性15例、均阴性7例;不一致6例(2例MFBG+/DOTA-TATE-,4例MFBG-/DOTA-TATE+)。
  • 区域水平:17例患者共86个复发或转移区域,18F-MFBG检出80个区域(灵敏度93.0%,特异性96.4%,AUC 0.947),68Ga-DOTA-TATE检出82个(灵敏度95.4%,特异性86.6%,AUC 0.910)。
  • 18F-MFBG特异性优势主要源于骨/骨髓转移灶摄取更高(中位SUVmax 5.21 vs. 2.90,P<0.0001)。
  • 区域水平一致阳性78个、不一致39个(9例MFBG+/DOTA-TATE-,30例MFBG-/DOTA-TATE+);总Curie评分两者均为155。
  • 因摄取模式互补,联合两种示踪剂可提高异质性肿瘤的视觉信心并优化疗效反应分类。

关键数值与推荐

  • 18F-MFBG区域水平灵敏度93.0%、特异性96.4%、AUC 0.947。
  • 68Ga-DOTA-TATE区域水平灵敏度95.4%、特异性86.6%、AUC 0.910。
  • 骨/骨髓转移灶中位SUVmax:18F-MFBG 5.21 vs. 68Ga-DOTA-TATE 2.90(P<0.0001)。

临床怎么用

  • 对疑似复发/难治性神经母细胞瘤患儿,可考虑18F-MFBG与68Ga-DOTA-TATE PET/CT互补使用以优化病灶检出和疗效反应评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To prospectively compare the diagnostic value of 18 F-meta-fluorobenzylguanidine ([ 18 F]MFBG) and [ 68 Ga]Ga-DOTA-TATE PET/CT in pediatric patients with suspected recurrent/refractory neuroblastoma. METHODS: Between December 2024 and March 2025, 28 children (18 boys, 10 girls; mean age ± SD 4.8 ± 2.5 y) underwent both tracers within 1 week at a single institution. Physiological biodistribution, image quality, lesion conspicuity, semiquantitative uptake (SUVmax), Curie score, and response classification were analyzed side-by-side. RESULTS: [ 18 F]MFBG showed higher background than [ 68 Ga]Ga-DOTA-TATE in skeletal muscle but lower activity in articular metaphyses, pituitary, and kidneys. Heterogeneous distribution of [ 18 F]MFBG was more common in the liver, while notable uptake differences were observed in the pancreas with [ 68 Ga]Ga-DOTA-TATE. Patient-level concordance was high (both scans positive in 15, negative in 7); discordance occurred in 6 patients (2 MFBG+/DOTA-TATE-, 4 MFBG-/DOTA-TATE+). Region-level analysis encompassed 86 relapsed or metastatic regions in 17 patients. [ 18 F]MFBG detected 80 regions (sensitivity 93.0%, specificity 96.4%, AUC 0.947), whereas [ 68 Ga]Ga-DOTA-TATE detected 82 (sensitivity 95.4%, specificity 86.6%, AUC 0.910). Superior specificity of [ 18 F]MFBG stemmed largely from its higher uptake in bone/marrow metastases compared with [ 68 Ga]Ga-DOTA-TATE (median SUVmax 5.21 vs. 2.90, P <0.0001). Region-level concordance revealed 78 concordant positive sites and 39 discordant sites (9 MFBG+/DOTA-TATE-, 30 MFBG-/DOTA-TATE+). Aggregate Curie scores were identical (155 each). Because uptake patterns were complementary, combining both tracers improved visual confidence in heterogeneous tumors and refined treatment-response categorization. CONCLUSIONS: [ 18 F]MFBG and [ 68 Ga]Ga-DOTA-TATE PET/CT imaging are effective for evaluating relapsed or metastatic neuroblastoma because they show lower uptake in normal organs and benign lesions. The 2 imaging modalities offer complementary value in tumor detection and assessment of treatment response due to tumor spatial heterogeneity.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Xu Q, Chen Y, Song J, et al. Head-to-Head Comparison of [ 18 F]MFBG and [ 68 Ga]Ga-DOTA-TATE PET/CT in Suspected Recurrent/Refractory Neuroblastoma: Prospective Single-center Analysis. Clin Nucl Med. 2026. PMID: 41627301. doi:10.1097/RLU.0000000000006308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。